OS Therapies up 65% as lung osteosarcoma asset meets goal in phase 2 trial
OS Therapies (NYSE:OSTX) is up ~65% in premarket trading Wednesday after releasing phase 2b data on OST-HER2 for prevention ...
MDAC inspection stickers to be USM black and gold in 2025
The school colors of Southern Miss are being featured prominently in 2025, in a new promotional campaign through the ...